LFST Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
LifeStance Health Group Inc (LFST) does not present a strong buy opportunity for a long-term beginner investor at this time. Despite recent price gains and bullish technical indicators, the lack of significant positive catalysts, insider selling, and neutral analyst ratings suggest caution. Holding the stock or waiting for more favorable conditions is advisable.
The stock is in a bullish trend with MACD positively expanding (0.109), RSI indicating overbought conditions (82.249), and moving averages showing bullish alignment (SMA_5 > SMA_20 > SMA_200). Resistance levels are at R1: 8.901 and R2: 9.331, while support levels are at S1: 7.511 and S2: 7.081.
Bullish technical indicators, recent price increase of 4.30% in the regular market, and positive pre-market and post-market changes.
Insiders are selling heavily with a 53168.39% increase in selling activity. Analysts have a neutral stance, and hedge funds are also neutral. No recent news or congress trading data to support a buy decision.
No financial data available for analysis.
Analysts are neutral overall. Goldman Sachs initiated coverage with a Neutral rating and a $9 price target. JPMorgan raised its price target to $9 but maintained a Neutral rating. BTIG and Canaccord have Buy ratings with price targets of $12 and $11, respectively, citing solid growth and strong Q1 performance.
